Skip to main content

Tweets

29% of new-onset psoriasis pts in Stockholm cohort developed PsA over 9,255 person-years. Two prediction models (AUC 0.804) identify: ➡ who to refer ➡ who will progress Key predictors: HLA-B27, CRP, enthesitis, arthralgia. @RheumNow #EULAR2025 #OP0178:

Jiha Lee @JihaRheum ( View Tweet )

10 months 2 weeks ago
The definition of MAS. MAS is secondary HLH. Other causes of secondary HLH are infections, malignancy and iatrogenic. Georgin-Lavialle S @RheumNow #EULAR2025 https://t.co/CpB78JBlVJ
Antoni Chan MD (Prof) @synovialjoints ( View Tweet )
10 months 2 weeks ago
Clinical Pearl's for #MAS Infections are still the most common cause. Next is malignancy... Then other causes like autoimmunity.. Ask a detailed history ! Sometimes check with the family when the pt can't give history.. #EULAR2025 @RheumNow https://t.co/fepercz5Af
Bella Mehta @bella_mehta ( View Tweet )
10 months 2 weeks ago
Total serum IL 18 can help instead of CDC42 or NLCR4 genetic testing in #MAS Several monogentic mutations in primary HLH- these panels can be available.. #EULAR2025 @RheumNow

Bella Mehta @bella_mehta ( View Tweet )

10 months 2 weeks ago
Age of onset is really important when thinking about #MAS Primary HLH more frequent in pediatric population. But can continue to adulthood. #EULAR2025 @RheumNow https://t.co/J7xmTiQiwr
Bella Mehta @bella_mehta ( View Tweet )
10 months 2 weeks ago
MAS can be triggered by infections in VEXAS syndrome. The threshold is reached leading to a hyperinflammatory state Georgin-Lavialle S @rheumnow #EULAR2025 https://t.co/NKLL75rOgP
Antoni Chan MD (Prof) @synovialjoints ( View Tweet )
10 months 2 weeks ago
#infections in #JAKi @drdavidliew #JAKi sl ⬆️ infection risk vs #TNFi ⬆️HZ w JAKi JAKi same risk w #latent #TB #LTBI and new TB ⬇️in JAKi v bDMARDs He didn’t discuss TYK2i Reassuring - risk⬇️ over time for infection @RheumNow #EULAR2025 @eular_org JAKi & infection https://t.co/KVsY2gXVkQ
Janet Pope @Janetbirdope ( View Tweet )
10 months 2 weeks ago
Management of HLH/MAS and modes of action of advanced therapies Jessica Manson @RheumNow #EULAR2025 https://t.co/Op3u53ZXeK
Antoni Chan MD (Prof) @synovialjoints ( View Tweet )
10 months 2 weeks ago
JAKi: expanding RMD indications—but important safety concerns to consider ⚠️ Cancer: Neutral vs MTX/placebo, ↑ risk vs TNF ⚠️ Infection: ↑ with age, disease activity & GC use—not uniformly higher with JAKi 🗣️ Patients rank infection risk as top concern @rheumnow #EULAR2025 https://t.co/RJRDWQjqNC
Jiha Lee @JihaRheum ( View Tweet )
10 months 2 weeks ago
Age & dose ⬆️ infections in JAKi Not all JAKi are created w equal risk ⁦@RheumNow⁩ ⁦@eular_org⁩ #EULAR2015 ⁦@drdavidliew⁩ #JAKi & #infection https://t.co/F7zLUBuzJR
Janet Pope @Janetbirdope ( View Tweet )
10 months 2 weeks ago
Stabilize the pts with HLH with steroids when still trying to figure out the diagnosis of #HLH/ #MAS Many drugs can be used...but important to balance infection risk with immunosuppression These are critical pts. Be vigilant.. #EULAR2025 @RheumNow https://t.co/id4ae3SWtj
Bella Mehta @bella_mehta ( View Tweet )
10 months 2 weeks ago
3 Fs of diagnosis of #HLH -Fever -Ferritin -Falling blood count Raising awareness is the key! Especially in rare diseases like this where the morbidity and mortality is super high! Collaboration between specialists help HLH networks will be helpful like this @RheumNow #EULAR2025 https://t.co/HWbvIma3yx
Bella Mehta @bella_mehta ( View Tweet )
10 months 2 weeks ago
×